Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0UV4H
|
||||
Former ID |
DIB011199
|
||||
Drug Name |
GSK-706769
|
||||
Synonyms |
GSK-163929; GSK-929; CCR5 antagonist (HIV), GSK; CCR5 antagonist (HIV), ViiV; CCR5 chemokine antagonists (HIV-1 infection),GlaxoSmithKline
|
||||
Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Phase 2 | [522788] | ||
Company |
GlaxoSmithKline plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
CC(C)(C(=O)N1CCC(CCN2CCC(CC2)N(C(=O)NCc2ccc(cc2)C#N)c2c<br />c(ccc2)F)(c2cccc(c2)F)CC1)O
|
||||
Target and Pathway | |||||
Target(s) | C-C chemokinereceptor type 5 | Target Info | Antagonist | [530181] | |
Pathway Interaction Database | IL12-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.